Company: MATV
Filing Date: 2025-04-22
Form Type: CORRESP
Source: 0001193125-25-089293
Chunk: 2

Company: Mativ Holdings, Inc.
Filing Date: 2025-04-22
Form: CORRESP
Chunk 2
---
 in the construction and automotive sectors. Future deterioration in these conditions 
 may require us to perform an interim quantitative impairment test in 2025.”                                                                                                                                                                               |

| 2 | See page 76 of the Company’s Form 10-K, which states:                                                                                                                                                                               
 “Changes to the forecasted revenue growth, earnings before income taxes, depreciation and amortization (“EBITDA”) and discount rate assumptions may result in a significantly different estimate of the fair value of the reporting 
 units, which could result in a different assessment of the recoverability of goodwill or measurement of an impairment charge.”                                                                                                      |

2

While significant estimates and assumptions related to forecasts of future cash flows used in the March 1, 2025 interim impairment test were generally aligned with those used in the annual impairment assessment performed as of October 1, 2024, the discount rates were increased to reflect a market participant view of additional risk associated with forecasted cash flows, specifically for the Filtration and Advanced Materials reporting unit (“FAM”). Further, the Company’s ability to achieve forecasted cash flows in FAM may be negatively impacted by factors including, but not limited to, deterioration of general economic conditions, increased competition in our end-markets,and the imposition of incremental tariffs and other trade barriers. Forecasted cash flows for the Company’s Sustainable and Adhesive Solutions reporting unit (“SAS”), are aligned with both growing and mature end markets, and are therefore subject to less risk. The size and impact of the impairment assessment is still being assessed by the Company and remains subject to finalization; however, we expect to record a material goodwill impairment charge related to FAM. The Company’s Form 10-Qfor the quarter ended March 31, 2025, and related earnings release for the period will include additional detail on the nature of the impairment and factors impacting the probability of future impairment charges. Notes to Consolidated Financial Statements Note 10. Goodwill, page 76

| 2. | We note that you changed your reportable segments during the first quarter of 2024 as part of an organizational                                                                                                                                      
 realignment. Please tell us whether the change in reportable segments impacted your existing reporting units prior to this change. If so, please tell us whether you performed an interim goodwill impairment test related to the existing reporting 
 units before the change. If not, explain why not. Refer to ASC 350-20-35-3(C)(f) and 350-20-35-45.                                                                                                                                                   |

Company Response: On